| 1 | 
																						 
											 Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810. 
																						 | 
										
																													
																							| 2 | 
																						 
											 Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts[J]. JAMA, 2014, 312 (1): 90-92. 
																						 | 
										
																													
																							| 3 | 
																						 
											 Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by payer, 2013: statistical brief #204[EB/OL]. [2022-03-22].  
																							 
																																					URL    
																																														 | 
										
																													
																							| 4 | 
																						 
											 Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395 (10219): 200-211. 
																						 | 
										
																													
																							| 5 | 
																						 
											 Demling R, LaLonde C, Saldinger P, et al. Multipleorgan dysfunction in the surgical patient: pathophysiology, prevention, and treatment[J]. Curr Probl Surg, 1993, 30 (4): 345-414. 
																						 | 
										
																													
																							| 6 | 
																						 
											 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等. 中国"脓毒症早期预防与阻断"急诊专家共识[J]. 中华危重病急救医学,2020,32(5):518-530. 
																						 | 
										
																													
																							| 7 | 
																						 
											 Dinarello CA. Historical insights into cytokines[J]. Eur J Immunol, 2007 (37 Suppl 1): S34-S45. 
																						 | 
										
																													
																							| 8 | 
																						 
											 Matsumoto H, Ogura H, Shimizu K, et al. The clinical importance of a cytokine network in the acute phase of sepsis[J]. Sci Rep, 2018, 8 (1): 13995. 
																						 | 
										
																													
																							| 9 | 
																						 
											 Sousa A, Raposo F, Fonseca S, et al. Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: association with severity and outcome[J]. Dis Markers, 2015: 747036. 
																						 | 
										
																													
																							| 10 | 
																						 
											 Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal[J]. Crit Care, 2020, 24 (1): 287. 
																						 | 
										
																													
																							| 11 | 
																						 
											 Denstaedt SJ, Singer BH, Standiford TJ. Sepsis and nosocomial infection: patient characteristics, mechanisms, and modulation[J]. Front Immunol, 2018 (9): 2446. 
																						 | 
										
																													
																							| 12 | 
																						 
											 Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes[J]. Lancet Respir Med, 2020, 8 (12): 1233-1244. 
																						 | 
										
																													
																							| 13 | 
																						 
											 Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harb Perspect Biol, 2014, 6 (10): a16295. 
																						 | 
										
																													
																							| 14 | 
																						 
											 Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF[J]. Blood, 1990, 75 (1): 40-47. 
																						 | 
										
																													
																							| 15 | 
																						 
											 Steensberg A, Fischer CP, Keller C, et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans[J]. Am J Physiol Endocrinol Metab, 2003, 285 (2): E433-E437. 
																						 | 
										
																													
																							| 16 | 
																						 
											 Henning DJ, Hall MK, Watsjold BK, et al. Inter-leukin-6 improves infection identification when added to physician judgment during evaluation of potentially septic patients[J]. Am J Emerg Med, 2020, 38 (5): 947-952. 
																						 | 
										
																													
																							| 17 | 
																						 
											 Cong S, Ma T, Di X, et al. Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis[J]. BMC Infect Dis, 2021, 21 (1): 384. 
																						 | 
										
																													
																							| 18 | 
																						 
											 Sun J, Madan R, Karp CL, et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10[J]. Nat Med, 2009, 15 (3): 277-284. 
																						 | 
										
																													
																							| 19 | 
																						 
											 Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy[J]. Nat Rev Immunol, 2013, 13 (12): 862-874. 
																						 | 
										
																													
																							| 20 | 
																						 
											 Zhou H, Li Z, Liang H, et al. Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study[J]. Platelets, 2022, 33(4): 612-620. 
																						 | 
										
																													
																							| 21 | 
																						 
											 张德厚,陈义坤,刘大东. 脓毒症患者早期血小板功能变化及预后分析[J/CD]. 中华危重症医学杂志(电子版),2017,10(1):28-33. 
																						 | 
										
																													
																							| 22 | 
																						 
											 张锦鑫,沈括,李俊杰,等. 脓毒症相关性急性肝损伤的流行病学特点及致病因素分析[J]. 中华急诊医学杂志,2022,31(2):203-209. 
																						 | 
										
																													
																							| 23 | 
																						 
											 田涛,李幼生. 脓毒症相关肝损害研究进展[J/CD]. 中华危重症医学杂志(电子版),2021,14(2):165-167. 
																						 | 
										
																													
																							| 24 | 
																						 
											 Park SH, Park CJ, Lee BR, et al. Sepsis affects most routine and cell population data (CPD) obtained using the Sysmex XN-2000 blood cell analyzer: neutrophil-related CPD NE-SFL and NE-WY provide useful information for detecting sepsis[J]. Int J Lab Hematol, 2015, 37 (2): 190-198. 
																						 | 
										
																													
																							| 25 | 
																						 
											 Montagnana M, Cervellin G, Meschi T, et al. The role of red blood cell distribution width in cardiovascular and thrombotic disorders[J]. Clin Chem Lab Med, 2011, 50 (4): 635-641. 
																						 | 
										
																													
																							| 26 | 
																						 
											 高兰,李昊,刘红娟,等. 尿酸联合红细胞分布宽度对脓毒症患者短期结局的预测价值[J/CD]. 中华危重症医学杂志(电子版),2019,12(6):367-371. 
																						 | 
										
																													
																							| 27 | 
																						 
											 McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer[J]. Curr Opin Clin Nutr Metab Care, 2009, 12 (3): 223-226. 
																						 | 
										
																													
																							| 28 | 
																						 
											 Huang Z, Fu Z, Huang W, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis[J]. Am J Emerg Med, 2020, 38 (3): 641-647. 
																						 | 
										
																													
																							| 29 | 
																						 
											 Boran OF, Yazar FM, Boran M, et al. The preseptic period and inflammatory markers in the prediction of the course of sepsis[J]. Med Sci Monit, 2018 (24): 3531-3539. 
																						 | 
										
																													
																							| 30 | 
																						 
											 Ferrer R, Mateu X, Maseda E, et al. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients[J]. Expert Rev Clin Pharmacol, 2018, 11 (2): 125-137. 
																						 | 
										
																													
																							| 31 | 
																						 
											 Godinez-Vidal AR, Correa-Montoya A, Enriquez-Santos D, et al. Is albumin a predictor of severity and mortality in patients with abdominal sepsis?[J]. Cir Cir, 2019, 87 (5): 485-489. 
																						 | 
										
																													
																							| 32 | 
																						 
											 Yin M, Si L, Qin W, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: a prospective cohort study[J]. J Intensive Care Med, 2018, 33 (12): 687-694. 
																						 | 
										
																													
																							| 33 | 
																						 
											 Omiya K, Sato H, Sato T, et al. Albumin and fibrinogen kinetics in sepsis: a prospective observational study[J]. Crit Care, 2021, 25 (1): 436. 
																						 | 
										
																													
																							| 34 | 
																						 
											 Klaude M, Mori M, Tjader I, et al. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis[J]. Clin Sci (Lond), 2012, 122 (3): 133-142. 
																						 | 
										
																													
																							| 35 | 
																						 
											 Peerapornratana S, Manrique-Caballero CL, Gomez H, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment[J]. Kidney Int, 2019, 96 (5): 1083-1099. 
																						 | 
										
																													
																							| 36 | 
																						 
											 Li X, Zheng R, Zhang T, et al. Association between blood urea nitrogen and 30-day mortality in patients with sepsis: a retrospective analysis[J]. Ann Palliat Med, 2021, 10 (11): 11653-11663. 
																						 | 
										
																													
																							| 37 | 
																						 
											 Han D, Zhang L, Zheng S, et al. Prognostic value of blood urea nitrogen/creatinine ratio for septic shock: an analysis of the MIMIC-Ⅲ clinical database[J]. Biomed Res Int, 2021: 5595042. 
																						 |